Site Search
Search Results
Understanding Provider Utilization of Cancer Biomarker Testing
Biomarker testing is an important step to accessing precision medicine, including targeted therapies that can lead to improved survivorship and better quality of life for cancer patients. However, not all communities are benefitting from the latest advancements in biomarker testing and precision medicine. ACS CAN is working to dismantle barriers that prevent patients from benefiting from biomarker testing and precision ...
Cancer Patients and Survivors Overwhelmingly Agree Biomarker Testing Improved Their Treatment
... to support ACS CAN’s advocacy work at all levels of government. Fielded September 12-25, 2023, our latest survey explores experiences with biomarker testing. The web-based survey was conducted among 1,222n cancer patients and survivors nationwide who have been diagnosed with or treated for cancer in the last seven years. Summary of Findings Higher Income and Education Groups are Most Likely to Report Having and Asking for Biomarker Testing About half (49%) of those surveyed have had biomarker testing for their cancer, while 29% say they have not and 22% are unsure. ...
Priority Issue
State
Policy Issue
- (-) Remove Access to Health Care filter Access to Health Care